| |
Key Select Aging & HIV Reports 2
An entire section on the NATAP website devoted to Aging & HIV.
|
| |
| |
http://www.natap.org/age.htm
--------------------------------
80% of HIV+ Are Over 45 / 20% over 60 /50% Over 50 in NY, SF, Boston, Florida- (01/27/17)
AGE:Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults....HIV+ have 2-4 times higher rates of impaired ability to perform daily functioning activities vs HIV-negatives
AGE:Up to Half in Older DC Cohort Not Treated for Metabolic Comorbidities - High Burden of Comorbidities in Inner City Washington DC
Aging in US - Worse Still To Come - polypharmacy, multiple comorbidities, decreased survival, impaired daily activities functioning- (12/21/16)
75% Predicted will be frail in 14 years, 60% frail now among older aging HIV+ and predicted 40% will have to be confined to old age homes as they will be disabled -IWCADRH:Future challenges for clinical care of an ageing population infected with HIV: a "geriatric-HIV" modelling study - [Healthcare Costs].... Very Sobering Analysis go Aging in HIV+....60% frail- (09/15/16)
Aging Older HIV+ have 3-6 Comorbidities & Are Taking 5-12 Medications -HIV+ >65 on Medicare Have 2 Times More Comorbidities vs HIV-neg AND Blacks & Latinos Have 4-Fold Increased Risk for the 5 Comorbidities Examined vs Whites - CDC Report Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection.- (10/08/16)
Here is a commentary I recently wrote:
Aging of HIV-Infected: a explosive and underestimated phenomena being ignored, needs attention - special support services for patients & clinics needed-lack of federal/state response - HCV too- (04/04/17)
Here are recent global impact study:
Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia - higher mortality, health-care utilization, worse quality of life, more comorbidities/geriatric conditions matched to uninfected- (05/22/17)
GLASGOW:HIV PATIENTS TODAY AND 10 YEARS AGO: DO THEY HAVE THE SAME NEEDS? RESULTS FROM CROSS SECTIONAL ANALYSIS OF ANRS CO3 AQUITAINE COHORT- (11/05/16)
GLASGOW:Quantifying the future clinical burden of an ageing HIV-positive population in Italy: a mathematical modelling study- (11/02/16)
Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study- (10/08/16)
IWCADRH:HIV duration of 20 Years in 75 year olds Doubles Multimorbidities & Polypharmacy Rates & This Causes Using HAART with Less Drugs in the Regimen - Silver champions from the GEPPO cohort (GEriatricPatients living with HIV/AIDS): a case control study of people above 75 years of age addressing Multimorbidity Polypharmacy and Antiretrovirals' Prescription in old HIV patients.- (09/16/16)
|
|
| |
| |
|
|
|
